PHARMACY

Spherix’s diabetes drug may lower HbA1c levels among patients with higher BMIs

BY Alaric DeArment

BETHESDA, Md. — Good results from an investigational diabetes drug made by Spherix may result from higher body mass indexes among U.S. patients, according to results of a late-stage clinical trial announced Thursday.

Spherix said results of the phase-3 trial conducted among American and Indian patients indicated that D-tagatose may be more effective in lowering HbA1c levels due to Americans having higher BMIs on average than Indians.

“Tagatose appears to be more effective in Type 2 diabetes patients with adipocyte dysfunction that no longer permits the adipocytes to act appropriately as an endocrine organ controlling HbA1c,” Spherix president Robert Lodder said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Forbes: Stewart Rahr’s newest pursuit is convincing Trump to challenge Obama in 2012

BY Jim Frederick

WHITESTONE, N.Y. — Fresh from securing a deal to sell his company to Cardinal Health for $1.3 billion, Kinray owner, president and CEO Stewart Rahr is turning more attention to his crusade to promote his friend Donald Trump as a candidate for president in 2012.

So reported Forbes magazine in its online edition. Forbes, which ranked Rahr as the 170th most wealthy American, reported that the colorful and well-connected billionaire is working hard to convince "The Donald" to run for the nation’s highest office.

Rahr agreed in November to sell Kinray, the nation’s top independently owned drug wholesaler, to Cardinal. The deal, expected to close early next year, presumably will leave Kinray’s former owner more time to devote himself to philanthropy — among other charitable pursuits, he is the largest donor behind the Make-A-Wish Foundation — and to back Trump as a Republican presidential candidate.

Among other actions, Rahr has lent his support to a newly launched website, ShouldTrumpRun.com, and issued a statement that seeks to solicit input and potential support for a presidential run by his friend. In that solicitation, he calls Trump “a natural born leader with outstanding ability to inspire others and to accomplish impossible tasks.” He also cited an independent poll from News Max to assert that Trump could win in a head-to-head contest versus President Barack Obama in 2012.

“This is only a starting point to evaluate in the immediate future the possibility that Mr. Trump would entertain running for the office of president of the United States,” Rahr told supporters. “Please join me in trying to convince Donald to consider running for this high office.”

In an interview with ABC News correspondent George Stephanopoulos, Trump described himself as a Republican, and said that if he decided to run, it would be as a Republican. He added, “I’m going to make a decision probably by June [of 2011].” Among the issues he’d champion: a more assertive stance with China, which he declared is gaining the upper hand against the United States in such areas as manufacturing and job creation. “I’m passionate about the country,” Trump told Stephanopoulos.

keyboard_arrow_downCOMMENTS

Leave a Reply

A.FEIN says:
Dec-08-2010 10:38 am

Jim, FYI, I posted Rahr's full email of support for Trump on Drug Channels: http://www.drugchannels.net/2010/12/if-donald-trump-becomes-us-president.html Adam

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?
PHARMACY

Gallup survey reaffirms pharmacists’ high standing

BY Jim Frederick

ALEXANDRIA, Va. — Community pharmacists still are among the nation’s most trusted professionals.

That’s the finding from Gallup’s newly released "Honesty and Ethics" survey. The polling firm reported that for the eighth consecutive year, Americans ranked pharmacists among the top three professional groups for honesty and trustworthiness, behind nurses and military officers. According to Gallup, 71% of respondents in its latest poll rated pharmacists’ honesty and ethical standards of pharmacists as “very high” or “high,” which marked an increase from 66% in 2009.

The National Association of Chain Drug Stores immediately hailed the survey results. “The public trust in pharmacists that is reflected in the Gallup survey provides further support for entrusting pharmacists with responsibilities that can help improve patients’ lives and reduce healthcare costs,” said NACDS president and CEO Steve Anderson Friday.

The poll results affirmed the increasingly critical role pharmacists can play in the nation’s beleaguered healthcare network, Anderson said. “Pharmacists are the face of neighborhood health care. They are highly accessible, with nearly all Americans living within 5 miles of a community pharmacy. They also are highly trusted — a concept that is supported again by the Gallup survey. We find that people are interested to hear about the education that pharmacists receive. To sit for pharmacy board licensure exams today, candidates must have a Doctor of Pharmacy degree, which requires a minimum of six years of professional education. Pharmacists are well qualified to meet the day-to-day needs of patients, as well as to help patients chart strategies to take their medications correctly,” Anderson added.

Similarly, the National Community Pharmacists Association praised the survey, stating that, “In business the common refrain is ‘the customer is always right’. The Gallup rating demonstrates the care pharmacists take in delivering indispensible prescription drug related services is appreciated. We hope to work with the public and private sector to grow pharmacists’ role in making Americans healthier, while helping to pursue the elusive, but attainable, goal of reducing costs,” the association said.

keyboard_arrow_downCOMMENTS

Leave a Reply

No comments found

TRENDING STORIES

Polls

Which area of the industry do you think Amazon's entry would shake up the most?